Tops & Flops Stocks
Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Glycomimetics Inc. | 6.190% | 11.633% | -86.527% | -85.406% | -87.898% | -86.256% | - |
MacroGenics Inc. | -13.920% | 30.579% | -74.433% | -28.321% | -55.400% | -83.233% | - |
Bone Therapeutics S.A. | -7.350% | 12.500% | -55.000% | -94.449% | -92.125% | -99.732% | -99.823% |
Sanai Health Industry Group Co. Ltd. | - | 0.000% | -50.000% | -92.857% | -90.000% | -93.333% | -98.000% |
EyePoint Pharmaceuticals Inc. | -2.170% | -2.987% | -47.133% | 99.633% | -49.159% | 52.168% | - |
Abeona Therapeutics Inc. | -2.360% | 4.103% | -45.135% | 47.208% | -13.800% | -85.539% | - |
Fennec Pharmaceuticals Inc. | 3.230% | -25.581% | -30.811% | -5.185% | -37.864% | 26.733% | 74.387% |
Fate Therapeutics Inc. | 2.390% | -5.299% | -27.332% | -22.519% | 1.012% | -94.278% | - |
Aspira Womens Health Inc. | -4.100% | -12.687% | -25.478% | -42.222% | -42.222% | -96.214% | -85.971% |
X4 Pharmaceuticals, Inc. | 2.390% | -9.852% | -24.659% | -56.287% | 13.205% | - | - |
Forte Biosciences Inc. | -7.630% | -15.504% | -23.776% | -42.632% | -15.504% | -97.820% | - |
Medigene AG | -0.340% | -3.051% | -22.703% | -9.779% | -10.063% | -63.380% | -82.792% |
Puma Biotechnology Inc. | -1.630% | -15.975% | -21.640% | 44.015% | -3.560% | -55.316% | - |
Carisma Therapeutics Inc. | -0.620% | -13.200% | -20.254% | -89.316% | -54.161% | -97.002% | -97.827% |
Akebia Therapeutics Inc. | 1.520% | -5.094% | -18.807% | 2.708% | -9.386% | -62.071% | - |
Rigel Pharmaceutical Inc. | -3.140% | -4.148% | -17.867% | -47.847% | -36.789% | -71.033% | - |
Chromadex Corp | -2.500% | -11.111% | -17.838% | 112.587% | 126.866% | -49.752% | - |
Matinas BioPharma Holdings Inc | 0.940% | -3.372% | -17.530% | -60.402% | -23.495% | -75.181% | - |
Lumos Pharma Inc. | -7.500% | -22.963% | -17.460% | -29.730% | -28.767% | -80.190% | -84.006% |
Intra-Cellular Therapies Inc. | -1.630% | -0.826% | -16.667% | 3.270% | -7.975% | 93.486% | 426.778% |
Cardio3 Biosciences S.A. | -6.210% | -11.071% | -16.583% | -53.717% | -27.826% | -94.587% | -98.523% |
Onxeo S.A. | -8.410% | -14.035% | -16.382% | -63.433% | -35.314% | -85.174% | -88.034% |
Atara Biotherapeutics Inc. | 0.250% | 15.479% | -16.271% | -70.253% | 10.415% | -95.224% | - |
Synthetic Biologics Inc. | 0.290% | 1.590% | -16.110% | -46.336% | -12.125% | -91.468% | -93.240% |
Enanta Pharmaceuticals Inc. | -6.780% | -5.172% | -14.729% | -52.586% | 25.000% | -72.906% | -86.458% |